Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
This Luxurious Thermal Spa In Italy Is Perfect For A Relaxing Escape While Visiting Milan - 2Famous Kitchen Finishing Styles For 2024
- 3The Most Enrapturing Authentic Milestones to Visit
- 4Fact Check: Some Bridge Photos Circulating Do NOT Show The Hongqi Bridge That Collapsed In Southwest China Nov. 11, 2025
- 5Figure out how to Consolidate All encompassing Practices with a Degree in Brain research
- Lockheed Martin opens new hypersonic weapons facility
- Remain Fit and Sound with These Exercise Fundamentals
- 6 Travel Services for Colorful Get-aways: Pick Your Fantasy Escape
- Car Investigation: A Survey of \Past the Outside\ Car
- Reporter's Notebook: The Post embeds with foreign armies visiting the IDF
- The most effective method to Shake Hands Expertly: A Bit by bit Guide
- Nations for Youngsters to Visit
- Significant Elements to Consider Prior to Applying for a Mastercard: 6 Vital Contemplations
- The Most Compelling Books of the 10 years
